🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sponsored by ZEISS Medical Technology. Check out Dr. Arnaldo Espaillat’s Case of the Month to learn how his experience with ZEISS PRESBYOND inspired him to expand his portfolio for patients seeking independence from glasses! Read here: hubs.li/Q03g7j3L0 #cornea #refractive

In a press release, Nordic Pharma, a subsidiary of Nordic Group B.V., announced that its canalicular gel Lacrifill has received CE Mark approval in the European Union. Read more: europe.ophthalmologytimes.com/view/canalicul…

A pioneer of refractive laser eye surgery in the UK, Professor David Gartry, MD, FRCS, FRCOphth, FCOptom, recently performed his 30,000th laser eye procedure. hubs.li/Q03hvMlZ0

New series alert! Join Aleksandra Rachitskaya, MD, and Jordan Graff, MD, FACS, as they cover novel drug delivery for retinal disease, such as PDS, faricimab, aflibercept, and more. Start watching now: hubs.li/Q03hgsw10 #retinaldisease #surgicaltechniques #clinicaltrials

The ASCRS meeting is underway, and the Eye Care Network is onsite! We can't wait to see you on the conference floor. #ASCRS #ASCRS2025

Today on the ASCRS Main Stage! #ASCRS2025

Bonnie An Henderson, MD, discussed the growing role of artificial intelligence in refractive surgery at the ASCRS annual meeting. "We use so many tools and toys, so AI is perfectly suited for ophthalmology," Dr. Henderson said. Hear more: hubs.li/Q03j_hpq0

Gregory Moloney, FRANZCO, FRCSC, presented a study on rotational stability and patient-reported outcomes with a monofocal plus toric IOL at the ASCRS annual meeting. Watch the full video: hubs.li/Q03j_hv-0

The peer-reviewed journal NEJM Evidence has published results from the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema (DME). hubs.li/Q03jYlNv0

At the ARVO meeting, Anat Loewenstein, MD, shared findings from a consensus group discussing management of diabetic retinopathy. "There were a few topics that achieved consensus," Prof Loewenstein said. Hear more, in her words: hubs.li/Q03lklcY0

Sponsored by ZEISS Medical Technology. Check out Dr. Arnaldo Espaillat’s Case of the Month to learn how his experience with ZEISS PRESBYOND inspired him to expand his portfolio for patients seeking independence from glasses! Read here: hubs.li/Q03g6_6q0 #cornea #refractive

Have we mentioned...we're at ARVO? Speakers, presenters and researchers made time to connect with the Eye Care Network brands. Nitish Mehta, MD, spoke about aflibercept 8 mg and diabetic macular oedema. Watch now, and see more from our partners: hubs.li/Q03lwW940

Get insights on the latest advances in retinal therapy: -PDS surgery -Clinical outcomes -Faricimab + aflibercept 8mg Hear the latest from Aleksandra Rachitskaya, MD, and Jordan Graff, MD, FACS. Watch: hubs.li/Q03mMQW_0 #IntravitrealTherapy #PortDeliverySystem

Glaucoma management is complex, but the right tools can make a difference. Discover advanced solutions that address key challenges in early detection, diagnosis, and patient management. Read now: hubs.li/Q03nh-qc0 #glaucoma #patientmanagement #HeidelbergEngineering